Achillion receives $2.

Achillion receives $2 .0 million in eight federal grants under QTDP program Achillion Pharmaceuticals, Inc. , a leader in the development and discovery of small molecule drugs to combat the most challenging infectious diseases, today announced that is has been awarded around $2.0 million in eight federal grants beneath the Qualifying Therapeutic Discovery Task plan.0 billion to reimburse certain costs paid or incurred during 2009 and 2010 directly linked to the conduct of a Qualifying Therapeutic Discovery Project. The Department of Health insurance and Human Providers designated such projects based on the potential for them to result in new therapies to take care of regions of unmet medical need, the potential to create and sustain careers in the U.S.